Eisai Co., Ltd. (4523) Other
Market cap
¥1.43T
P/E ratio
33.2x
Eisai develops, manufactures and sells prescription drugs and over-the-counter medicines globally across Japan, North America, China, Europe and Asia.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | 7.3 | 5.3 | 5.7 | 6 | 11.4 | 3.9 | 4.1 | 4.4 | 3.2 | 3.3 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 10,730 | 10,495 | 10,419 | 10,183 | 9,877 | 10,452 | 10,456 | 10,683 | 10,998 | 11,237 | 11,322 | 11,076 | 11,067 | 10,917 |
| Total payout ratio | - | - | - | - | - | - | - | - | - | - | - | - | 108.3 | 162.9 |